Clinical Trial Update: "InDACtion" vs "3+7" Induction in AML [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing InDACtion versus 3+7 induction in acute myeloid leukemia is ongoing, with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• 3+7 induction
• InDACtion

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Acute Myeloid Leukemia (AML) | Phase 3 | Status: UNKNOWN